Pathophysiology of perinatal brain damage

Brain Research Reviews

Volumn 30, Issue 2, 1999, Pages 107-134

  Berger, Richard ^a   Garnier, Yves ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Brain damage; Perinatal; Post ischemic

Indexed keywords

CALCIUM; ENDONUCLEASE; GLUTAMIC ACID; MAGNESIUM; NEUROTRANSMITTER; NITRIC OXIDE; OXYGEN RADICAL; PROTEINASE; TRIACYLGLYCEROL LIPASE;

ADRENERGIC STIMULATION; APOPTOSIS; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PERFUSION; CALCIUM BALANCE; ENERGY METABOLISM; FETUS HYPOXIA; HEART OUTPUT; INDUCED HYPOTHERMIA; INTRAVENOUS DRUG ADMINISTRATION; NERVE CELL NECROSIS; NEUROTRANSMISSION; OXIDATIVE PHOSPHORYLATION; PERINATAL MORBIDITY; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; REVIEW; UMBILICAL CORD BLOOD FLOW; UTERUS BLOOD FLOW;

ANIMALS; ASPHYXIA NEONATORUM; BRAIN; BRAIN DAMAGE, CHRONIC; CEREBRAL PALSY; FEMALE; HUMANS; INFANT, NEWBORN; PREGNANCY;

EID: 0032848049     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(99)00009-0     Document Type: Review

References (357)

1. Abdel-Rahman A., Parks J.K., Deveraux M.W., Sokol R.J., Parker W.D. Jr., Rosenberg A.A. Developmental changes in newborn lamb brain mitochondrial activity and postasphyxial lipid peroxidation. PSEBM. 209:1995;170-177.
2. Aitken P.G., Balestrino M., Somjen G.G. NMDA antagonists: lack of protective effect against hypoxic damage in CA1 region of hippocampal slices. Neurosci. Lett. 89:1988;187-192.
3. Al-Khalidi U.A.S., Chaglassian T.H. The specific distribution of xanthine oxidase. J. Biochem. 97:1965;318-320.
4. Albers G.W., Goldberg M.P., Choi D.W. Do NMDA antagonists prevent neuronal injury? Arch. Neurol. 49:1992;418-420.
5. Altman D.I., Young R.S.K., Yagel S.K. Effects of dexamethasone in hypoxic/ischemic brain injury in the neonatal rat. Biol. Neonate. 46:1984;149-156.
6. Altura B., Altura B.M. Withdrawal of magnesium causes vasospasm while elevated magnesium produces relaxation of tone in cerebral arteries. Neurosci. Lett. 20:1980;323-327.
7. Amato M., Fauchere J.C., Hermann U. Jr. Coagulation abnormalities in low birth weight infants with peri-intraventricular hemorrhage. Neuropediatrics. 19:1988;154-157.
8. Ames A., Wright R.L., Kowada M., Thurston J.M., Majno G. Cerebral ischemia: II. The no-reflow phenomenon. Am. J. Pathol. 52:1968;437-453.
9. An G., Lin T.-N., Liu X.-S., Xue J.-J., He Y.-Y., Hsu Cy. Expression of c-fos and c-jun family genes after focal cerebral ischemia. Ann. Neurol. 33:1993;457-464.
10. Andine P., Lehmann A., Ellren K., Wennberg E., Kjellmer I., Nielsen T., Hagberg H. The excitatory amino acid antagonist kynurenic acid administered after hypoxic ischemia in neonatal rat offers neuroprotection. Neurosci. Lett. 90:1988;208-212.
11. Armstrong D., Norman M.G. Periventricular leucomalacia in neonates. Complications and sequelae. Arch. Dis. Child. 49:1974;367-375.
12. Ashwal S., Dale P.S., Longo L.D. Regional cerebral blood flow: studies in the fetal lamb during hypoxia, hypercapnia, acidosis, and hypotension. Pediatr. Res. 18:1984;1309-1316.
13. Ashwal S., Cole D.J., Osborne S., Osborne T.N., Pearce W.J. L-NAME reduces infarct volume in a filament model of transient middle cerebral artery occlusion in the rat pup. Pediatr. Res. 38:1995;652-656.
14. Bagenholm R., Andine P., Hagberg H. Effects of the 21-amino steroid tirilazad mesylate (U74006F) on brain damage and edema after hypoxia-ischemia in the rat. Pediatr. Res. 40:1995;399-403.
15. Banker B.Q., Larroche J.C. Periventricular leukomalacia of infancy. Arch. Neurol. 7:1962;386-410.
16. Barks J.D.E., Post M., Tuor U.I. Dexamethasone prevents hypoxic/ischemic brain damage in the neonatal rat. Pediatr. Res. 29:1991;558-563.
17. Barmada M.A., Moossy J., Shuman R.M. Cerebral infarcts with arterial occlusion in neonates. Ann. Neurol. 6:1979;495-502.
18. Beck T., Bielenberg G.W. The effects of two 21-aminosteroids on overt infarct size 48 hours after middle cerebral artery occlusion in the rat. Brain. Res. 560:1991;159-162.
19. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. 87:1990;1620-1624.
20. J.S. Beckman, H. Ischiropoulos, J. Chen, Nitric oxide as a mediator of superoxide-dependent injury, in: K.J.A. Davies (Ed.), Oxidative Damage and Repair. Chemical, Biological and Medical Aspects, Pergamon, Oxford, 1992, 251 pp.
21. J.S. Beckman, J. Chen, H. Ischiropoulos, K.A. Conger, Inhibition of nitric oxide synthesis and cerebral protection, in: J. Krieglstein, H. Oberpichler-Schwenk (Eds.), Pharmacology of Cerebral Ischemia, Wissenschaftliche Verlasggesellschaft, Stuttgart, 1992, 383 pp.
22. Bejar R., Vigliocco G., Gramajo H., Solana C., Benirschke K., Berry C., Coen R. Antenatal origin of neurologic damage in newborn infants: II. Multiple gestations. Am. J. Obstet. Gynecol. 162:1990;1230-1236.
23. F.C. Benedikt, R.C. Lee, Hibernation and marmot physiology. Carnegie Institution of Washington, Publication no. 494, Washington, DC, 1938.
24. Benveniste H., Drejer J., Schousboe A., Diemer N.M. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1984;1369-1374.
25. Benirschke K. The contribution of placental anastomoses to prenatal twin damage. Hum. Pathol. 23:1992;1319-1320.
26. Benson D.W., Williams G.R., Spencer F.C., Yates E. The use of hypothermia after cardiac arrest. Anesth. Analg. 38:1959;423-428.
27. Berger R., Jensen A., Krieglstein J., Steigelman J.P. Effects of acute asphyxia on brain energy metabolism in fetal guinea pigs near term. J. Dev. Physiol. 16:1991;9-11.
28. Berger R., Jensen A., Krieglstein J., Steigelman J.P. Cerebral energy metabolism in immature and mature guinea pig fetuses during acute asphyxia. J. Dev. Physiol. 18:1992;125-128.
29. Berger R., Jensen A., Krieglstein J., Steigelmann J.P. Cerebral energy metabolism in fetal guinea pigs during moderate maternal hypoxemia at 0.75 of gestation. J. Dev. Physiol. 19:1993;193-196.
30. Berger R., Gjedde A., Heck J., Müller E., Krieglstein J., Jensen A. Extension of the 2-deoxyglucose method to the fetus in utero: theory and normal values for the cerebral glucose consumption in fetal guinea pigs. J. Neurochem. 63:1994;271-279.
31. Berger R., Djuricic B., Jensen A., Hossmann K.-A., Paschen W. Ontogenetic differences in energy metabolism and inhibition of protein synthesis in hippocampal slices during in vitro ischemia and 24 h of recovery. Dev. Brain. Res. 91:1996;281-291.
32. Berger R., Djuricic B., Jensen A., Hossmann K.-A., Paschen W. Mild hypothermia provides neuroprotection in an in vitro model of fetal cerebral ischemia. J. Soc. Gynecol. Invest. 3:1996;391.
33. Berger R., Lehmann T., Karcher J., Schachenmayr W., Jensen A. Relation between cerebral oxygen delivery and neuronal cell damage in fetal sheep near term. Reprod. Fertil. Dev. 8:1996;317-321.
34. Berger R., Bender S., Sefkow S., Klingmüller V., Künzel W., Jensen A. Peri/intraventricular haemorrhage: a cranial ultrasound study on 5286 neonates. Eur. J. Obstet. Gynecol. Reprod. Biol. 75:1997;191-203.
35. Berger R., Gjedde A., Hargarter L., Hargarter S., Krieglstein J., Jensen A. Regional cerebral glucose utilization in immature fetal guinea pigs during maternal isocapnic hypoxemia. Pediatr. Res. 42:1997;311-316.
36. Berger R., Jensen A., Hossmann K.-A., Paschen W. No effect of glutamate on metabolic disturbances in hippocampal slices of mature fetal guinea pigs after transient in vitro ischemia. Dev. Brain Res. 101:1997;49-56.
37. Berger R., Jensen A., Hossmann K.-A., Paschen W. Effect of mild hypothermia during and after transient in vitro ischemia on metabolic disturbances in hippocampal slices at different stages of development. Dev. Brain Res. 105:1998;67-77.
38. Berger R., Jensen A., Paschen W. Metabolic disturbances in hippocampal slices of fetal guinea pigs during and after oxygen-glucose deprivation: is nitric oxide involved? Neurosci. Lett. 245:1998;163-166.
39. Berger R., Lehmann T., Karcher J., Garnier Y., Jensen A. Low dose flunarizine protects the fetal brain from ischemic injury in sheep. Pediatr. Res. 44:1998;277-282.
40. Biegon A., Joseph A.B. Development of HU-211 as a neuroprotectant for ischemic brain damage. Neurol. Res. 17:1995;275-280.
41. Bigelow W.G., Lindsay W.K., Harrison R.C. Oxygen transport and utilization in dogs at low body temperatures. Am. J. Physiol. 160:1950;125-137.
42. Bliss T.V.P., Collingridge G.L. A synaptic model of memory: long term potentiation in the hippocampus. Nature. 361:1993;31-39.
43. Blumberg R.M., Cady E.B., Wigglesworth J.S., McKenzie J.E., Edwards A.D. Relation between delayed impairment of cerebral energy metabolism and infarction following transient focal hypoxia-ischaemia in the developing brain. Exp. Brain Res. 113:1997;130-137.
44. Blumenfeld K.S., Welsh F.A., Harris V.A., Pesenson M.A. Regional expression of c-fos and heat shock protein-70 mRNA following hypoxia-ischemia in immature rat brain. J. Cereb. Blood Flow Metab. 12:1992;987-995.
45. Bodsch W., Takahashi K., Barbier A., Grosse Ophoff B., Hossmann K.-A. Cerebral protein synthesis and ischemia. Prog. Brain Res. 63:1985;197-210.
46. Bordarier C., Robain O. Microgyric necrotic corticol lesions in twin fetuses - original cerebral damage consecutive to twinning. Brain Dev. 14:1992;174-178.
47. Boterell E.H., Lougheed W.M., Scott J.W., Vandewater S.L. Hypothermia, and interruption of carotid, or carotid and vertebral circulation, in the surgical management of intracranial aneurysms. J. Neurosurg. 13:1956;1-42.
48. Brown A.K., McGarry J.A. Eclampsia with hyperpyrexia: a case treated by total body cooling. Scott. Med. J. 6:1961;311-313.
49. Buchan A.M. Do NMDA antagonists prevent neuronal injury? Arch. Neurol. 49:1992;420-421.
50. Buchan A.M., Gertler S.Z., Huang Z.G., Li H., Chaundy K.E., Xue D. Failure to prevent selective CA1 neuronal death and reduce cortical infarction following cerebral ischemia with inhibition of nitric oxide. Neuroscience. 61:1994;1-11.
51. O. Bumke, O. Foerster, Handbuch der Neurologie, Band XVI. Verlag von Julius Springer, Berlin, 1936.
52. Busciglio J., Yankner B.A. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature. 378:1995;776-779.
53. Busto R., Dietrich W.D., Globus M.Y.T., Valdés I., Scheinberg P., Ginsberg M.D. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J. Cereb. Blood Flow Metab. 7:1987;729-738.
54. Busto R., Globus M.Y.T., Dietrich W.D., Martinez E., Valdés I., Ginsberg M.D. Effect of mild hypothermia on ischemic-induced release of neurotransmitters and free fatty acids in rat brain. Stroke. 20:1989;904-910.
55. Caldwell M., O'Neill M., Earley B., Leonard B. NG-nitro-L-arginine protects against ischaemia-induced increases in nitric oxide and hippocampal neuro-degeneration in the gerbil. Eur. J. Pharmacol. 260:1994;191-200.
56. Cao X., Phillis J.W. The free radical scavenger, alpha-lipoic acid, protects against cerebral ischemia-reperfusion injury in gerbils. Free Radical Res. 23:1995;365-370.
57. Cardell M., Boris-Miller F., Wieloch T. Hypothermia prevents the ischemia-induced translocation and inhibition of protein kinase C in the rat striatum. J. Neurochem. 57:1991;1814-1817.
58. Carter A.J., Mueler R.E. Activation of excitatory amino acid receptors cannot alone account for anoxia-induced impairment of protein synthesis in rat hippocampal slices. J. Neurochem. 57:1991;888-896.
59. Cavazutti M., Duffy T.E. Regulation of local cerebral blood flow in normal and hypoxic newborn dogs. Ann. Neurol. 11:1982;247-257.
60. Chan P.H., Yang G.Y., Chen S.F. Cold-induced brain edema and infarction are reduced in transgenic mice overexpressing CuZn-superoxide dismutase. Ann. Neurol. 29:1991;482-486.
61. Cheng Y., Deshmukh M., D'Costa A., Demaro J.A., Gidday J.M., Shah A., Sun Y., Jacquin M.F., Johnson E.M., Holtzman D.M. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J. Clin. Invest. 101:1998;1992-1999.
62. Choi D.W. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. TINS. 11:1988;465-469.
63. Choi D.W. Excitotoxic cell-death. J. Neurobiol. 23:1992;1261-1276.
64. Chopp M., Knight R., Tidwell C.D., Helpern J.A., Brown E., Welch K.M.A. The metabolic effects of mild hypothermia on global cerebral ischemia and recirculation in the cat: comparison to normothermia and hypothermia. J. Cereb. Blood Flow Metab. 9:1989;141-148.
65. Chumas P.D., Del Bigio M.R., Drake J.M., Tuor U.I. A comparison of the protective effect of dexamethasone to other potential prophylactic agents in a neonatal rat model of cerebral hypoxia/ischemia. J. Neurosurg. 79:1993;414-420.
66. Churn S.B., Taft W.C., Billingsley M.S., Blair R.E., DeLorenzo R.J. Temperature modulation of ischemic neuronal death and inhibition of calcium/calmodulin-dependent protein kinase II in gerbils. Stroke. 21:1990;1715-1721.
67. Coimbra C., Wieloch T. Moderate hypothermia mitigates neuronal damage in the rat brain when initiated several hours following transient ischemia. Acta Neuropathol. 87:1994;325-331.
68. Cotman C.W., Monaghan D.T. Anatomical organization of excitatory amino acid receptors and their properties. Adv. Exp. Med. Biol. 203:1986;237-252.
69. Cotton D.B., Janusz C.A., Berman R.F. Anticonvulsant effects of magnesium sulphate on hippocampal seizures: therapeutic implications in pre-eclampsia-eclampsia. Am. J. Obstet. Gynecol. 166:1992;1127-1136.
70. Coyle J.T., Enna S.J. Neurochemical aspects of the ontogenesis of GABAergic neurons in the rat brain. Brain Res. 111:1976;119-133.
71. Craig T.V., Hunt W., Atkinson R. Hypothermia - its use in severe carbon monoxide poisoning. N. Engl. J. Med. 261:1976;854-856.
72. Cruikshank D.P., Pitkin R.M., Reynolds W.A., Williams G.A., Hargis G.K. Effects of magnesium sulfate treatment on perinatal calcium metabolism. Am. J. Obstet. Gynecol. 134:1979;243-249.
73. Crumrin R., Thomas A., Morgan P. Attenuation of p53 expression protects against focal ischemic damage in transgenic mice. J. Cereb. Blood Flow Metab. 14:1994;887-891.
74. Dalkara T., Moskowitz M.A. The complex role of nitric oxide in the pathophysiology of focal cerebral ischemia. Brain Pathol. 4:1994;49-57.
75. Dambska M., Laure-Kamionowska M., Schmidt-Sidor B. Early and late neuropathological changes in white matter damage. J. Child. Neurol. 4:1989;291-298.
76. Davies K.J.A. Protein damage and degradation by oxygen radicals: I. General aspects. J. Biol. Chem. 262:1987;9895-9901.
77. Davies K.J.A., Goldberg A.L. Oxygen radicals stimulate intracellular proteolysis and lipid peroxidation by independent mechanisms in erythrocytes. J. Biol. Chem. 262:1987;8220-8226.
78. Dawson D.A. Nitric oxide and focal ischemia: multiplicity of actions and diverse outcome. Cerebrovasc. Brain Metab. Rev. 6:1994;299-324.
79. De Reuck J.L. Cerebral angioarchitecture and perinatal brain lesions in premature and full-term infants. Acta Neurol. Scand. 70:1984;391-395.
80. de la Monte S.M., Hsu F.I., Hedly-Whyte E.T., Kupsky W. Morphometric analysis of the human infant brain: effects of intraventricular hemorrhage and periventricular leukomalacia. J. Child. Neurol. 5:1990;101-110.
81. de Vries L.S., Wigglesworth J.S., Regev R., Dubowitz L.M. Evolution of periventricular leukomalacia during the neonatal period and infancy: correlation of imaging and postmortem findings. Early Hum. Dev. 17:1988;205-219.
82. Dell'Anna E., Chen Y., Loidl F., Andersson K., Luthman J., Goiny M., Rawal R., Lindgren T., Herrera-Marschitz M. Short-term effects of perinatal asphyxia studied with fos-immunocytochemistry and in vivo microdialysis in the rat. Exp. Neurol. 131:1995;279-287.
83. Dietrich W.D., Busto R., Halley M., Valdés I. The importance of brain temperature in alterations of the blood-brain barrier following cerebral ischemia. J. Neuropathol. Exp. Neurol. 49:1990;486-497.
84. Djuricic B., Rihn G., Paschen W., Hossmann K.-A. Protein synthesis in the hippocampal slice: transient inhibition by glutamate and lasting inhibition by ischemia. Metab. Brain Dis. 9:1994;235-247.
85. Dragunow M., Beilharz E., Sirimanne E., Lawlor P., Williams C.E., Bravo R., Gluckman P.D. Immediate-early gene protein expression in neurons undergoing delayed death, but not necrosis, following hypoxic-ischemic injury to the young rat brain. Mol. Brain Res. 25:1994;19-33.
86. Drake C.G., Barr H.W.K., Coles J.C., Gergely N.F. The use of extracorporal circulation and profound hypothermia in the treatment of ruptured intracranial aneurysm. J. Neurosurg. 21:1964;575-581.
87. Dux E., Oschlies U., Wiessner C., Hossmann K.-A. Glutamate-induced ribosomal disaggregation and ultrastructural changes in rat cortical neuronal culture - protective effect of horse serum. Neurosci. Lett. 141:1992;173-176.
88. East S.J., Garthwaite J. NMDA receptor activation in rat hippocampus induces cGMP formation through the L-arginine-nitric oxide pathway. Neurosci. Lett. 123:1991;17-19.
89. El-Deiry W., Tokino T., Velculescu V., Levy D., Parsons R., Trent J., Lin D., Mercer W., Kinzler K., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
90. Etzioni A. Adhesion molecules - their role in health and disease. Pediatr. Res. 39:1996;191-198.
91. Fellman V., Raivio K.O. Reperfusion injury as the mechanism of brain damage after perinatal asphyxia. Pediatr. Res. 41:1996;599-606.
92. Ferriero D.M., Soberano H.Q., Simon R.P., Sharp F.R. Hypoxia-ischemia induces heat shock protein-like (HSP72) immunoreactivity in neonatal rat brain. Dev. Brain Res. 53:1990;145-150.
93. Ford L.M., Sanberg P.R., Norman A.B., Fogelson M.H. MK-801 prevents hippocampal neurodegeneration in neonatal hypoxic-ischemic rats. Arch. Neurol. 46:1989;1090-1096.
94. Fridovich I. The biology of the oxygen radicals. The superoxide radical is an agent of oxygen toxicity; superoxide dismutases provide an important defense. Science. 201:1978;875-880.
95. Fridovich I. Superoxide radical: an endogenous toxicant. Annu. Rev. Pharmacol. Toxicol. 23:1983;239-257.
96. R.L. Friede, Developmental Neuropathology, Springer-Verlag, New York, 1989.
97. Funato M., Tamai H., Noma K., Kurita T., Kajimoto Y., Yoshioka Y., Shimada S. Clinical events in association with timing of intraventricular hemorrhage in preterm infants. J. Pediatr. 121:1992;614-619.
98. Garnier Y., Löbbert T., Jensen A., Berger R. Lack of neuroprotection by glutamate antagonist lubeluzole after transient global cerebral ischemia in fetal sheep. J. Soc. Gynecol. Invest. 5:1998;F513.
99. Garthwaite J. Glutamate, nitric oxide and cell-cell signaling in the nervous system. Trends Neurosci. 14:1991;60-67.
100. Gehrmann J., Bonnekoh P., Miyazawa T., Oschlies U., Duz E., Hosmann K.-A., Kreutzberg G.W. The microglia reaction in the rat hippocampus following global ischemia: immunoelectron microscopy. Acta Neuropathol. 84:1992;588-595.
101. Gilland E., Puka-Sundvall M., Andine P., Bona E., Hagberg H. Hypoxic-ischemic injury in the neonatal rat brain: effects of pre- and post-treatment with the glutamate release inhibitor BW1003C87. Dev. Brain Res. 83:1994;79-84.
102. F.H. Gilles, A. Leviton, E.C. Dooling, The Developing Human Brain: Growth and Epidemiologic Neuropathology. John Wright PSG, Boston, 1983.
103. M.D. Ginsberg, M.Y.T. Globus, E. Martinez, T. Morimoto, B. Lin, H. Schnipperin, O.F. Alonso, R. Busto, Oxygen radical and excitotoxic processes in brain ischemia and trauma, in: J. Krieglstein, H. Oberpichler-Schwenk (Eds.), Pharmacology of Cerebral Ischemia, Wissenschaftliche Verlagsgesellschaft, Stuttgart, 1994, 255 pp.
104. Globus M.Y.T., Busto R., Dietrich W.D., Martinez E., Valdés I., Ginsberg M.D. Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis. J. Neurochem. 51:1988;1455-1464.
105. Globus M.Y.T., Busto R., Dietrich W.D., Ginsberg M.D. The protective effect of intraischemic mild cerebral hypothermia is associated with inhibition of extracellular glutamate release during ischemia. Ann. Neurol. 24:1988;127-128.
106. Goldberg R.N., Chung D., Goldman S.L., Bancalari E. The association of rapid volume expansion and intraventricular hemorrhage in the preterm infant. J. Pediatr. 96:1980;1060-1063.
107. Goplerud J.M., Mishra O.P., Delivoria-Papadopoulos M. Brain cell membrane dysfunction following acute asphyxia in newborn piglets. Biol. Neonate. 61:1992;33-41.
108. Goto K., Ishige A., Sekiguchi K., Iizuka S., Sugimoto A., Yuzurihara M., Aburada M., Hosoya E., Kogure K. Effects of cycloheximide on delayed neuronal death in rat hippocampus. Brain Res. 534:1990;299-302.
109. Granger D.N. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am. J. Physiol. 255:1988;HI269-HI275.
110. Green E.J., Dietrich W.D., van Dijk F., Busto R., Markgraf C.G., McCabe P.M., Ginsberg M.D., Schneiderman N. Protective effect of brain hypothermia on behavior and histopathology following global cerebral ischemia in rats. Brain Res. 580:1992;197-204.
111. Green K.W., Key T.C., Coen R., Resnik R. The effects of maternally administered magnesium sulfate on the neonate. Am. J. Obstet. Gynecol. 146:1983;29-33.
112. Grether J.K., Nelson K.B. Maternal infection and cerebral palsy in infants of normal birth weight. JAMA. 278:1997;207-211.
113. Grether J.K., Hoogstrate J., Selvin S., Nelson K.B. Magnesium sulfate toxicolysis and risk of neonatal death. Am. J. Obstet. Gynecol. 178:1998;1-6.
114. Gunn A.J., Mydlar T., Bennet L., Faull R.L.M., Gorter S., Cook C., Johnston B.M., Gluckman P.D. The neuroprotective actions of a calcium antagonist, flunarizine, in the infant rat. Pediatr. Res. 25:1989;573-576.
115. Gunn A.J., Williams C.E., Mallard E.C., Tan W.K.M., Gluckman P.D. Flunarazine, a calcium channel antagonist, is partially prophylactically neuroprotective in hypoxic/ischemic encephalopathy in the fetal sheep. Pediatr. Res. 35:1994;657-663.
116. Gunn A.J., Gunn T.R., de Haan H.H., Williams C.E., Gluckman P.D. Dramatic neuronal rescue with prolonged selective head cooling after ischemia in fetal lambs. J. Clin. Invest. 99:1997;248-256.
117. Gunn A.J., Gluckman P.D., Gunn T.R. Selective head cooling in newborn infants after perinatal asphyxia: a safety study. Pediatrics. 102:1998;885-892.
118. Gunn A.J., Gunn T.R., Gunning M.I., Williams C.E., Gluckman P.D. Neuroprotection with prolonged head cooling started before postischemic seizures in fetal sheep. Pediatrics. 102:1998;1098-1106.
119. Hadjiconstantinou M., Yates A.J., Neff N.H. Hypoxia-induced neurotransmitter deficits in neonatal rats are partially corrected by exogenous GM1 ganglioside. J. Neurochem. 55:1990;864-869.
120. Hagberg H., Gilland E., Diemer N.H., Andine P. Hypoxia-ischemia in the neonatal rat brain: histopathology after post treatment with NMDA and non-NMDA receptor antagonists. Biol. Neonate. 66:1994;205-213.
121. Hai T., Curran T. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. U.S.A. 88:1991;3720-3724.
122. Hajakawa T., Hamada Y., Maihara T., Hattori H., Mikawa H. Phenytoin reduces neonatal hypoxic/ischemic brain damage in rats. Life Sci. 54:1994;387-392.
123. Hajakawa T., Higuchi Y., Nigami H., Hattori H. Zonisamide reduces hypoxic/ischemic brain damage in neonatal rats irrespective of its anticonvulsive effect. Eur. J. Pharmacol. 257:1994;131-136.
124. Hall E.D., Braughler J.M., Yonkers P.A., Smith S.L., Linseman K.L., Means E.D., Scherch H.M., Von Voigtlander P.F., Lahti R.A., Jacobsen E.J. U-78517F: a potent inhibitor of lipid peroxidation with activity in experimental brain injury and ischemia. J. Pharmacol. Exp. Ther. 258:1991;688-694.
125. Hallenbeck J.M., Dutka A.J., Tanishima T., Kochanek P.M., Kumaroo K.K., Thopmpson C.B., Obrenvovich T.P., Contreras T.P. Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period. Stroke. 17:1986;246-253.
126. Halliwell B., Gutteridge J.M.C. Oxygen radicals and the nervous system. Trends Neurosci. 8:1985;22-26.
127. Halliwell B., Gutteridge J.M.C., Cross C.E. Free radicals, antioxidants, and human disease: where are we now? J. Lab. Clin. Med. 199:1992;599-620.
128. Hamada Y., Hayakama T., Hattori H., Mikawa H. Inhibitor of nitric oxide synthesis reduces hypoxic/ischemic brain damage in the neonatal rat. Pediatr. Res. 35:1994;10-14.
129. Hamada J., Greenberg J.H., Croul S., Dawson T.M., Reivich M. Effects of central inhibition of nitric oxide synthase on focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 15:1995;779-786.
130. Hambleton G., Wigglesworth J.S. Origin of intraventricular haemorrhage in the preterm infant. Arch. Dis. Child. 51:1976;651-659.
131. Hansen P.R. Role of neutrophils in myocardial ischemia and reperfusion. Circulation. 91:1995;1872-1885.
132. Hansen A.J. Effect of anoxia on ion distribution in the brain. Physiol. Rev. 65:1985;101-148.
133. Harper J., Adami G., Wei N., Keyomarsi K., Elledge S. The p21 CDK-interacting protein Cip1 is a potent inhibitor of cyclin dependent kinases. Cell. 75:1993;805-816.
134. Hartmann J.F., Becker R.A., Cohen M.M. Cerebral ultrastructure in experimental hypoxia and ischemia. Monogr. Neurol. Sci. 1:1973;50-64.
135. Hasegawa K., Yoshioka H., Sawada T., Nishikawa H. Direct measurement of free radicals in the neonatal mouse brain subjected to hypoxia: an electron spin resonance spectroscopic study. Brain Res. 607:1993;161-166.
136. Hasegawa K., Litt L., Espanol M.T., Gregory G.A., Sharp F.R., Chan P.H. Effects of neuroprotective dose of fructose-1,6-bisphosphate on hypoxia-induced expression of c-fos and hsp70 mRNA in neonatal rat cerebrocortical slices. Brain Res. 750:1997;1-10.
137. Hattori H., Morin A.M., Schwartz P.H., Fujikawa D.G., Waterlain C.G. Posthypoxic treatment with MK-801 reduces hypoxic/ischemic damage in the neonatal rat. Neurology. 39:1989;713-718.
138. M.A. Helfaer, J.R. Kirsch, R.J. Traystman, Radical scavengers: penetration into brain following ischemia and reperfusion, in: J. Krieglstein, H. Oberpichler-Schwenk (Eds.), Pharmacology of Cerebral Ischemia, Medpharm Scientific Publishers, Stuttgart, 1994, 297 pp.
139. Hernandez L.A., Grisham M.B., Twohig B., Arfors K.E., Harlan J.M., Granger D.N. Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am. J. Physiol. 253:1987;H699-H703.
140. Higuchi Y., Hattori H., Hattori R., Furusho K. Increased neurons containing neuronal nitric oxide synthase in the brain of hypoxic-ischemic neonatal rat model. Brain Dev. 18:1996;369-375.
141. Higuchi Y., Hattori H., Kume T., Tsuji M., Akaike A., Furusho K. Increase in nitric oxide in the hypoxic-ischemic neonatal rat brain and suppression by 7-nitroindazole and aminoguanidine. Eur. J. Pharmacol. 342:1998;47-49.
142. Hill A., Perlman J.M., Volpe J.J. Relationship of pneumothorax to occurrence of intraventricular hemorrhage in the premature newborn. Pediatrics. 69:1982;144-149.
143. Hope P.L., Gould S.J., Howard S., Hamilton P.A., Costello A.M., Reynolds E.O. Precision of ultrasound diagnosis of pathologically verified lesions in the brains of very preterm infants. Dev. Med. Child Neurol. 30:1988;457-471.
144. Hossmann K.-A., Kleihues P. Reversibility of ischemic brain damage. Arch. Neurol. 29:1973;375-384.
145. K.-A. Hossmann, R. Widmann, C. Wiessner, E. Dux, B. Djuricic, G. Röhn, Protein synthesis after global cerebral ischemia and selective vulnerability, in: J. Krieglstein, H. Oberpichler-Schwenk (Eds.), Pharmacology of Cerebral Ischemia, Wissenschaftliche Verlagsgesellschaft, Stuttgart, 1992, 289 pp.
146. Hossmann K.-A. Ischemia-mediated neuronal injury. Resuscitation. 26:1993;225-235.
147. K.-A. Hossmann, Mechanisms of ischemic injury: is glutamate involved? in: J. Krieglstein, H. Oberpichler-Schwenk (Eds.), Pharmacology of Cerebral Ischemia, Wissenschaftliche Verlagsgesellschaft, Stuttgart, 1994, 239 pp.
148. Houdou S., Takashima S., Takeshita K., Ohta S. Infantile subcortical leukohypodensity demonstrated by computed tomography. Pediatr. Neurol. 4:1988;165-167.
149. Howell D.A., Stratford J.G., Posnikoff J. Prolonged hypothermia in treatment of massive cerebral haemorrhage. A preliminary report. Can. Med. Assoc. J. 75:1956;388-394.
150. Huang Z., Huang P.L., Panahian N., Dalkara T., Fishman M.C., Moskowitz M.A. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 265:1994;1883-1885.
151. Hudome S., Palmer C., Roberts R.L., Mauger D., Housman C., Towfighi J. The role of neutrophils in the production of hypoxic-ischemic brain injury in the neonatal rat. Pediatr. Res. 41:1996;607-616.
152. Hurst R.W., Kerns S.R., McIllhenny J., Park T.S., Cail W.S. Neonatal dural venous sinus thrombosis associated with central venous catheterization: CT and MR studies. J. Comput. Assist. Tomogr. 13:1989;504-507.
153. Ischiropoulos H., Zhu L., Chen J., Tsai M., Martin J.C., Smith C.D., Beckman J.S. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch. Biochem. Biophys. 298:1992;1-7.
154. Jayaraman L., Prives C. Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell. 81:1995;1021-1029.
155. Jensen A., Hohmann M., Künzel W. Dynamic changes in organ blood flow and oxygen consumption during acute asphyxia in fetal sheep. J. Dev. Physiol. 9:1987;543-559.
156. Jensen A., Berger R. Fetal circulatory responses to oxygen lack. J. Dev. Physiol. 16:1991;181-207.
157. Jensen A., Klingmüller V., Künzel W., Sefkow S. Das Hirnblutungsrisiko bei Früh-und Reifgeborenen. Geburtsh. u. Frauenheilk. 52:1992;6-20.
158. Jensen F.E., Applegate C.D., Holtzman D., Belin T.R., Burchfiel J.L. Epileptogenic effects of hypoxia on immature rodent brain. Ann. Neurol. 29:1991;629-637.
159. Jensen F.E., Blume H., Alvarado S., Firkusny I., Geary C. NBQX blocks the acute and late epileptogenic effects of perinatal hypoxia. Epilepsia. 36:1995;966-972.
160. Jensen F.E. Perinatal hypoxic-ischemic brain injury: maturation-dependent relation to epilepsy. MRDD Res. Rev. 3:1997;85-95.
161. Jiang K., Kim S., Murphy S., Song D., Pastuszko A. Effect of hypoxia and reoxygenation on regional activity of nitric oxide synthase in brain of newborn piglets. Neurosci. Lett. 206:1996;199-203.
162. Johannsson H., Siesjö B.K. Cerebral blood flow and oxygen consumption in the rat in hypoxic hypoxia. Acta Physiol. Scand. 93:1975;269-276.
163. Johnson G.N., Palahniuk R.J., Tweed W.A. Regional cerebral blood flow changes during severe fetal asphyxia produced by slow partial umbilical cord compression. Am. J. Obstet. Gynecol. 135:1997;48-52.
164. Kass I.S., Lipton P. Calcium and long term transmission damage following anoxia in dentate gyrus and CA1 regions of the rat hippocampal slice. J. Physiol. 37:1986;313-324.
165. Kass I.S., Cotrell J.E., Cambers G. Magnesium and cobalt, not nimodipine, protect neurons against anoxic damage in the rat hippocampal slice. Anesthesiology. 69:1988;710-715.
166. Kastan M., Zan Q., El-Deiry W., Carrier F., Jacks T., Walsh W., Plunkett B., Vogelstein B., Fornace A.J. A mammalian cell cycle checkpoint pathway utilizing p53 and Gadd45 is defective in ataxia-telangiectasia. Cell. 71:1992;587-597.
167. M. Khrestchatisky, S. Timsit, S. Rivera, E. Tremblay, Y. Ben-Ari, Neuronal death and damage repair: roles of protooncogenes and cell cycle-related proteins, in: J. Krieglstein (Ed.), Pharmacology of Cerebral Ischemia, Medpharm Scientific Publishers, Stuttgart, 1996, 41 pp.
168. Kinuta Y., Kimura M., Itokawa Y., Ishikawa M., Kikuchi H. Changes in xanthine oxidase in ischemic rat brain. J. Neurosurg. 71:1989;417-420.
169. Kirino T., Sano K. Final structure of delayed neuronal cell death following ischemia in gerbil hippocampus. Acta Neuropathol. (Berlin). 62:1984;209-218.
170. Kleihues P., Hossmann K.-A., Pegg A.E., Kobayashi K., Zimmermann V. Resuscitation of the monkey brain after one hour of complete ischemia: III. Indications of metabolic recovery. Brain Res. 95:1975;61-73.
171. Knuckey N.W., Palm D., Primano M., Epstein M.H., Johanson C.E. N-acetylcysteine enhances hippocampal neuronal survival after transient forebrain ischemia in rats. Stroke. 26:1995;305-310.
172. Kobayashi S., Welsh F.A. Regional alterations of ATP and heat-shock protein-72 mRNA following hypoxia-ischemia in neonatal rat brain. J. Cereb. Blood Flow Metab. 15:1995;1047-1056.
173. Kochhar A., Zivin J.A., Lyden P.D., Mazzarella V. Glutamate antagonist therapy reduces neurologic deficits produced by focal central nervous system ischemia. Arch. Neurol. 45:1988;148-153.
174. Kramer R.S., Sanders A.P., Lesage A.M. The effect of profound hypothermia on preservation of cerebral ATP content during circulatory arrest. J. Thorac. Cardiovasc. Surg. 56:1968;699-709.
175. Kuban K.C., Gilles F.H. Human telencephalic angiogenesis. Ann. Neurol. 17:1985;539-548.
176. Kuluz J.W., Prado R.J., Dietrich W.D., Schleien C.L., Watson B.D. The effect of nitric oxide synthase inhibition on infarct volume after reversible focal cerebral ischemia in conscious rats. Stroke. 24:1993;2023-2029.
177. Kure S., Tominaga T., Yoshimoto T., Tada K., Narisawa K. Glutamate triggers internucleosomal DNA cleavage in neuronal cells. Biochem. Biophys. Res. Commun. 179:1991;39-45.
178. J.C. Larroche, Developmental Pathology of the Neonate, Excerpta Medica, New York, 1977.
179. J.C. Larroche, Intraventricular hemorrhage in the premature neonate, in: R. Korbkin, C. Guilleminault (Eds.), Advances in Perinatal Neurology, Vol. 1., SP Medical and Scientific Books, New York, 1979.
180. Larroche J.C. Fetal encephalopathies of circulatory origin. Biol. Neonate. 50:1986;61-74.
181. Lassen N.A. Brain extracellular pH: the main factor controlling cerebral blood flow. Scan. J. Clin. Lab. Invest. 22:1968;247-251.
182. Lauritzen M., Hansen A.J. The effect of glutamate receptor blockade on anoxic depolarization and cortical spreading depression. J. Cereb. Blood Flow Metab. 12:1992;223-229.
183. Le Blanc M.H., Vig V., Smith B., Parker C.C., Evans O.B., Smith E.E. MK-801 does not protect against hypoxic/ischemic brain injury in piglets. Stroke. 22:1991;1270-1275.
184. Le Blanc M.H., Vig V., Ranhawa T., Smith E.E., Parker C.C., Brown E.G. Use of polyethylene glycol-bound superoxide dismutase, polyethylene glycol-bound catalase, and nimodipine to prevent hypoxic ischemic injury to the brain of newborn pigs. Crit. Care Med. 21:1993;252-259.
185. Lee S., Elenbaas B., Levine A. p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion deletion mismatches. Cell. 81:1995;1013-1020.
186. Lekieffre D., Ghribi O., Callebert J., Allix M., Plotikine M., Boulu R.G. Inhibition of glutamate release in rat hippocampus by kynurenic acid does not protect CA1 cells from forebrain ischemia. Brain Res. 592:1992;333-337.
187. Lewis F.J., Taufic M. Closure of atrial septal defects with aid of hypothermia: experimental accomplishments and the report of one successful case. Surgery. 33:1953;52-59.
188. Li Y., Chopp M., Zhang Z., Zaloga C., Niewenhuis L., Gautam S. p53 immunoreactive protein and p53 mRNA expression after transient middle cerebral artery occlusion in rats. Stroke. 25:1994;849-856.
189. Li Y., Chopp M., Zhang Z.G., Zaloga C. Induction of DNA fragmentation after 10 to 120 minutes of focal cerebral ischemia in rats. Stroke. 26:1995;1252-1258.
190. Lin Y., Phillips J.W. Oxypurinol reduces focal ischemia brain injury in the rat. Neurosci. Lett. 126:1991;187-190.
191. Linnik M.D., Zahos P., Geschwind M.D., Federoff H.J. Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia. Stroke. 26:1995;1670-1675.
192. Lipsitz P.J. The clinical and biochemical effects of excess magnesium in the newborn. Pediatrics. 47:1971;501-509.
193. Longo L.D. Hypoxia-ischaemia and the developing brain: hypotheses regarding the pathophysiology of fetal-neonatal brain damage. Br. J. Obstet. Gynaecol. 104:1997;652-662.
194. Lou H.C., Lassen N.A., Tweed W.A., Johnson G., Jones M., Palahniuk R.J. Pressure passive cerebral blood flow and breakdown of the blood-brain barrier in experimental fetal asphyxia. Acta Paediatr. Scand. 68:1979;57-63.
195. Lou H.C., Tweed W.A., Davies J.M. Preferential blood flow increase to the brain stem in moderate neonatal hypoxia: reversal by naloxone. Eur. J. Pediatr. 144:1985;225-227.
196. Lougheed W.M., Sweet W.H., White J.C., Brewster W.R. The use of hypothermia in surgical treatment of cerebral vascular lesions. A preliminary report. J. Neurosurg. 12:1955;240-255.
197. Lupton B.A., Hill A., Whitfield M.F., Carter C.J., Wadsworth L.D., Roland E.H. Reduced platelet count as a risk factor for intraventricular hemorrhage. Am. J. Dis. Child. 142:1988;1222-1224.
198. Lynch R.E., Fridovich I. Permeation of erythrocyte stroma by superoxide radicals. J. Biol. Chem. 253:1978;4697-4699.
199. Ma X.-L., Tsao P.S., Lefer A.M. Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion. J. Clin. Invest. 88:1991;1237-1243.
200. MacDermott A.B., Mayer M.L., Westbrook G.L., Smith S.J., Barker J.L. NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurons. Nature. 321:1986;519-522.
201. McDonald J.W., Silverstein F.S., Johnson M.W. MK-801 protects the neonatal brain from hypoxic/ischemic damage. Eur. J. Pharmacol. 140:1987;359-361.
202. Maher J., Hachinski V. Hypothermia as a potential treatment for cerebral ischemia. Cerebrovasc. Brain Metab. Rev. 5:1993;277-300.
203. Mannino F.L., Trauner D.A. Stroke in neonates. J. Pediatr. 102:1983;605-610.
204. Marks K.A., Mallard C.E., Roberts I., Williams C.E., Gluckman P.D., Edwards A.D. Nitric oxide synthase inhibition attenuates delayed vasodilation and increases injury after cerebral ischemia in fetal sheep. Pediatr. Res. 40:1996;185-191.
205. Marshall T.A., Marshall F., Reddy P.P. Physiologic changes associated with ligation of the ductus arteriosus in preterm fetuses. J. Pediatr. 101:1982;749-753.
206. Martin D., Chinookoswong N., Miller G. The interleukin-1 receptor antagonist (rhIL-1ra) protects against cerebral infarction in a rat model of hypoxia/ischemia. Exp. Neurol. 130:1994;362-367.
207. Martin L.J., Blackstone C.D., Levey A.I., Huganir R.L., Price D.L. AMPA glutamate receptor subunits are differentially distributed in rat. Brain Neurosci. 53:1993;327-358.
208. Martz D., Rayos G., Schielke G.P., Betz A.L. Allopurinol and dimethylthiourea reduce brain infarction following middle cerebral artery occlusion in rats. Stroke. 20:1989;488-494.
209. Matsuo Y., Onodera H., Shiga Y., Nakamura M., Ninomya M., Kihara T., Kogure K. Correlation between myeoloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion. Stroke. 25:1994;1469-1475.
210. McCord J.M. Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med. 312:1985;159-163.
211. McDonald J.W., Silverstein F.S., Johnson M.W. MK-801 protects the neonatal brain from hypoxic/ischemic damage. Eur. J. Pharmacol. 140:1987;359-361.
212. McIntosh T.K., Vink R., Yamakami I., Faden A.I. Magnesium protects against neurological deficit after brain injury. Brain Res. 482:1989;252-260.
213. McManus J.P., Buchan A.M., Hill I.E., Rasquinha I., Preston E. Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain. Neurosci. Lett. 164:1993;89-92.
214. McRae A., Gilland E., Bona E., Hagberg H. Microglia activation after neonatal hypoxia-ischemia. Dev. Brain Res. 84:1995;245-252.
215. Mehmet H., Yue X., Squier M.V., Lorek A., Cady E., Penrice J., Sarraf C., Wylezinska M., Kirkbridge V., Cooper C., Brown G.C., Wyatt J.S., Reynolds E.O.R., Edwards A.D. Increased apoptosis in the cingulate sulcus of newborn piglets following transient hypoxia-ischemia is related to the degree of high energy phosphate depletion during the insult. Neurosci. Lett. 181:1994;121-125.
216. Meldrum B. Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters. Clin. Sci. 68:1985;113-122.
217. Mello Filho A.C., Hoffman M.E., Meneghini R. Cell killing and DNA damage by hydrogen peroxide are mediated by intracellular iron. J. Biochem. 218:1984;273-275.
218. Michenfelder J.D., Theye R.A. Hypothermia: effect on canine brain and whole body metabolism. Anaesthesiology. 29:1968;1107-1112.
219. Michenfelder J.D., Theye R.A. The effects of anesthesia and hypothermia on canine cerebral ATP and lactate during anoxia produced by decapitation. Anaesthesiology. 33:1970;430-439.
220. Milligran D.W. Failure of autoregulation and intraventricular haemorrhage in preterm infants. Lancet. 1:1980;896-898.
221. Minami M., Kurashi Y., Yabuuchi K., Yamazaki A., Satoh M. Induction of interleukin-1β mRNA in rat brain after transient forebrain ischemia. J. Neurochem. 58:1992;390-392.
222. Mink R.B., Dutka A.J., Hallenbeck J.M. Allopurinol pretreatment improves evoked response recovery following global cerebral ischemia in dogs. Stroke. 22:1991;660-665.
223. Mishra O.P., Delivoria-Papadopoulos M. Lipid peroxidation in developing fetal guinea pig brain during normoxia and hypoxia. Dev. Brain Res. 45:1989;129-135.
224. Mitani A., Andou Y., Kataoka K. Selective vulnerability of hippocampal CA 1 neurons cannot be explained in terms of an increase in glutamate concentration during ischemia in the gerbil brain. Neuroscience. 48:1992;307-313.
225. Mittendorf R., Covert R., Boman J., Khoshnood B., Lee K.-S., Siegler M. Is tokolytic magnesium sulphate associated with increased total paediatric mortality? Lancet. 350:1997;1517-1518.
226. Miyashita T., Harigai M., Hanada M., Reed J. Identification of a p53 dependent negative response element in the bcl-2 gene. Cancer Res. 54:1994;3131-3155.
227. Miyashita T., Krajewski S., Krajewski M., Wang H., Lin H., Liebermann D., Hoffmann B., Reed J. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 9:1994;1799-1805.
228. Miyashita T., Reed J. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 80:1995;293-299.
229. Monaghan D.T., Bridges R.J., Cotman C.W. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu. Rev. Pharmacol. Toxicol. 29:1989;365-402.
230. Moody D.M., Brown W.R., Challa V.R., Block S.M. Alkaline phosphatase histochemical staining in the study of germinal matrix hemorrhage and brain vascular morphology in a very low birth-weight neonate. Pediatr. Res. 35:1994;424-430.
231. Morioka T., Kalehua A.N., Streit W.J. Progressive expression of immunomolecules on microglial cells in rat dorsal hippocampus following transient forebrain ischemia. Acta Neuropathol. 83:1992;149-157.
232. Munell F., Burke R.E., Bandele A., Gubits R.M. Localization of c-fos, c-jun, and hsp70 mRNA expression in brain after neonatal hypoxia-ischemia. Dev. Brain Res. 77:1994;111-121.
233. Nagufuji T., Sugiyama M., Matsui T., Koide T. A narrow therapeutical window of a nitric oxide synthase inhibitor against transient ischemic brain injury. Eur. J. Pharmacol. 248:1993;325-328.
234. Nakamura Y., Okudera T., Fukuda S., Hashimoto T. Germinal matrix hemorrhage of venous origin in preterm neonates. Hum. Pathol. 21:1990;1059-1062.
235. Nathan C.F. Nitric oxide as secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
236. Negrin J. Selective local hypothermia in neurosurgery. N.Y. State J. Med. 61:1961;2951-2965.
237. Nelson K.B., Gretherm J.K. Can magnesium sulfate reduce the risk of cerebral palsy in very low birth-weight infants? Pediatrics. 95:1995;263-269.
238. Nicoletti F., Wroblewski J.T., Novelli A., Alho H., Guidotti A., Costa E. The activation of inositol phospholipid metabolism as a signal-transducing system for excitatory amino acids in primary cultures of cerebellar granule cells. J. Neurosci. 6:1986;1905-1911.
239. Nishikawa T., Kirsch J.R., Koehler R.C., Bredt D.S., Snyder S.H., Traystman R.J. Effect of nitric oxide synthase inhibition on cerebral blood flow and injury volume during focal ischemia in cats. Stroke. 24:1993;1717-1724.
240. Norman M.G. Perinatal brain damage. Perspect. Pediatr. Pathol. 4:1978;41-92.
241. M.G. Norman, The pathology of perinatal asphyxia, Can. Med. Assoc. J. (Suppl.) 1988, pp. 15-20.
242. Norman M.G., McGillivray Fetal neuropathology of proliferative vasculopathy and hydranencephaly-hydrocephaly with multiple limb pterygia. Pediatr. Neurosci. 14:1988;301-306.
243. Nowak L., Bregestovski P., Ascher P., Herbet A., Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurones. Nature. 307:1984;462-465.
244. Nowicki J.P., Duval D., Poignet H., Scatton B. Nitric oxide mediates neuronal cell death after focal ischemia in the mouse. Eur. J. Pharmacol. 204:1991;339-340.
245. Nozaki K., Beal M.F. Neuroprotection effects of L-kynurenine on hypoxic-ischemic and NMDA lesions in neonatal rats. J. Cereb. Blood Flow Metab. 12:1992;400-407.
246. Nozaki K., Finkelstein S.P., Beal M.F. Basic fibroblast growth factor protect against hypoxia/ischemia in neonatal rats. J. Cereb. Blood Flow Metab. 13:1993;221-228.
247. T.P. Obrenovitch, J. Urenjak, E. Zilkha, Excitotoxicity in cerebral ischemia: alternative hypothesis to high extracellular glutamate, in: J. Krieglstein (Ed.), Pharmacology of Cerebral Ischemia, Medpharm Scientific Publishers, Stuttgart, 1996, 9 pp.
248. Ohrt B., Riegel R., Wolke D. Langzeitprognose sehr kleiner Frühgeborener. Arch. Gynecol. Obstet. 257:1995;480-492.
249. Oillet J., Koziel V., Vert P., Daval J.-L. Influence of post-hypoxia reoxygenation conditions on energy metabolism and superoxide production in cultured neurons from the rat forebrain. Pediatr. Res. 39:1996;598-603.
250. Okada Y., Copeland B.R., Mori E., Tung M.M., Thomas W.S., del Zoppo G.J. P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion. Stroke. 25:1994;202-211.
251. Olney J.W. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science. 164:1969;719-721.
252. Olney J.W., Sharpe L.G., Feigin R.D. Glutamate-induced brain damage in infant primates. J. Neuropathol. Exp. Neurol. 31:1972;464-488.
253. Olney J.W., Ikonomidou J.L., Mosinger J.L., Friedrich G. MK-801 prevents hypobaric-ischemic neuronal degeneration in infant rat brain. J. Neurosci. 9:1989;1701-1704.
254. Palacios J.M., Niehoff D.L., Kuhar M.J. Ontogeny of GABA and benzodiazepine receptors: effects of Triton X-100-bromide and muscimol. Brain Res. 179:1979;390-395.
255. Palmer C., Vannucci R.C., Towfighi J. Reduction of perinatal hypoxic-ischemic brain damage with allopurinol. Pediatr. Res. 27:1990;332-336.
256. Palmer C., Towfighi J., Roberts R.L., Heitjan D.F. Allopurinol administered after inducing hypoxia/ischemia reduces brain injury in 7-days-old rats. Pediatr. Res. 33:1993;405-411.
257. Palmer C., Roberts R.L., Bero C. Deferoxamine posttreatment reduces ischemic brain injury in neonatal rats. Stroke. 25:1994;1039-1045.
258. Palmer C. Hypoxic-ischemic encephalopathy. Therapeutic approaches against microvascular injury, and the role of neutrophils, PAF, and free radicals. Clin. Perinatol. 22:1995;481-517.
259. Palmer C., Roberts R.L., Young P.I. Neutropenia before but not after hypoxia/ischemia reduces brain injury in neonatal rats. J. Cereb. Blood Flow Metab. 15:1995;291.
260. Paneth N., Rudelli R., Monte W., Rodriguez E., Pinto J., Kairam R., Kazam E. White matter necrosis in very low birth weight infants: neuropathologic and ultrasonographic findings in infants surviving six days or longer. J. Pediatr. 116:1990;975-984.
261. K.E. Pape, J.S. Wigglesworth, Haemorrhage, ischaemia and the perinatal brain, JB Lippincott, Philadelphia, 1979.
262. Park C.K., Nehls D.G., Teasdale G.M., McCulloch J. The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat. Ann. Neurol. 24:1988;543-551.
263. Parkhouse J. General anesthesia as an aid to therapeutic hypothermia. Br. Med. J. 2:1957;751.
264. Paschen W. Disturbances of calcium homeostasis within the endoplasmic reticulum may contribute to the development of ischemic-cell damage. Med. Hypotheses. 47:1996;283-288.
265. Paschen W., Doutheil J., Gissel C., Treiman M. Depletion of neuronal endoplasmic reticulum calcium stores by thapsigargin: effect on protein synthesis. J. Neurochem. 67:1996;1735-1743.
266. Patt A., Horesh I.R., Berger E.M., Harken A.H., Repine J.E. Iron depletion or chelation reduces ischemia/reperfusion-induced edema in gerbil brains. J. Pediatr. Surg. 25:1990;224-228.
267. Patten R.M., Mack L.A., Nyberg D.A., Filly R.A. Twin embolization syndrome: prenatal sonographic detection and significance. Radiology. 173:1989;685-689.
268. Penrice J., Lorek A., Cady E.B., Amess P.N., Wylenezinska M., Cooper C.E., D'Souza P., Brown G.C., Kirkbridge V., Edwards A.D., Wyatt, Reynolds E.O.R. Proton magnetic resonance spectroscopy of the brain during acute hypoxia-ischemia and delayed cerebral energy failure in the newborn piglet. Pediatr. Res. 41:1997;795-802.
269. Perides G., Jensen F.E., Edgecomb P., Rueger D.C., Charnes M.E. Neuroprotective effect of human osteogenic protein-1 in a rat model of cerebral hypoxia ischemia. Neurosci. Lett. 187:1995;21-24.
270. Pryds O., Greisen G., Lou H., Friis-Hansen B. Vasoparalysis associated with brain damage in asphyxiated term infants. J. Pediatr. 117:1990;119-125.
271. Quast M.J., Wei J., Huang N.C. Nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester decreases ischemic damage in reversible focal ischemia in hyperglycemic rats. Brain Res. 677:1995;204-212.
272. Ram Z., Sadeh M., Shacked I., Sahar A., Hadani M. Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke. 22:1991;922-927.
273. Ratan R.R., Murphy T.H., Barban J.M. Oxidative stress induces apoptosis in embryonic corticol neurons. J. Neurochem. 62:1994;376-379.
274. Reed J. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124:1994;1-2.
275. M. Reivich, A.W. Brann, Jr., H.M. Shapiro, Regional cerebral blood flow during prolonged partial asphyxia, in: J.S. Meyer, M. Reivich, H. Lechner (Eds.), Research on the Cerebral Circulation, Thomas, Springfield, IL, 1972.
276. Roessmann U., Gambetti P. Pathological reaction of astrocytes in perinatal brain injury. Immunohistochemical study. Acta Neuropathol. (Berlin). 70:1986;302-307.
277. Romson J.L., Hook B.G., Kunkel S.L., Abrams G.D., Schork M.A., Lucchesi B.R. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation. 67:1983;1016-1023.
278. L.B. Rorke, Pathology of Perinatal Brain Injury, Raven Press, New York, 1982.
279. Rorke L.B. Anatomical features of the developing brain implicated in pathogenesis of hypoxic-ischemic injury. Brain Pathol. 2:1992;211-221.
280. Rosenbaum D.M., Michaelson M., Batter D.K., Doshi P., Kessler J.A. Evidence for hypoxia-induced, programmed cell death of cultured neurons. Ann. Neurol. 36:1994;864-870.
281. 2 metabolism after asphyxia in neonatal lambs. Pediatr. Res. 20:1986;778-782.
282. Rosenberg A.A., Murdaugh E., White C.W. The role of oxygen free radicals in postasphyxia cerebral hypoperfusion in newborn lambs. Pediatr. Res. 26:1989;215-219.
283. Rothman S.M. Synaptic activity mediates death of hypoxic neurons. Science. 220:1983;536-537.
284. Rothman S.M. Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death. J. Neurosci. 4:1984;1884-1891.
285. Rothman S.M., Olney J.W. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann. Neurol. 19:1986;105-111.
286. Rothman S.M. Synaptic activity mediates death by hypoxic neurons. Science. 220:1989;536-537.
287. Rothwell N.J., Hopkins S.J. Cytokines and the nervous system. II. Actions and mechanisms of action. Trends Neurol. Sci. 18:1995;130-136.
288. Rudolph A.M., Heymann M.A. Cardiac output in the fetal lamb: the effects of spontaneous and induced changes of heart rate on right and left ventricular output. Am. J. Obstet. Gynaecol. 124:1976;183-192.
289. Sakhi S., Bruce A., Sun N., Tocco G., Baudry M., Schreiber S. p53 induction is associated with neuronal damage in the central nervous system. Proc. Natl. Acad. Sci. 91:1994;7525-7529.
290. Scheller J.M., Nelson K.B. Twinning and neurologic morbidity. Am. J. Dis. Child. 146:1992;1110-1113.
291. Schendel D.E., Berg C.J., Yeargin-Allsopp M., Boyle C.A., Decoufle P. Prenatal magnesium sulfate exposure and risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years. JAMA. 276:1996;1805-1810.
292. H. Schmid-Schönbein, Microrheology of erythrocytes and thrombocytes, blood viscosity and the distribution of blood flow in the microcirculation, in: H.W. Altmann, F. Büchner, H. Cottier (Eds.), Handbuch der Allgemeinen Pathologie III/7: Mikrozirkulation. Springer, Berlin, 1977, 289 pp.
293. Schoepfer R., Monyer H., Sommer B., Wisden W., Sprengel R., Kuner T., Lomeli H., Herb A., Kohler M., Burnashev N., Gunther W., Ruppersberg P., Seeburg P. Molecular biology of glutamate receptors. Prog. Neurobiol. 42:1994;353-357.
294. Sedzimir C.B. Therapeutic hypothermia in cases of head injury. J. Neurosurg. 16:1959;407-414.
295. Seelig J.M., Wei E.P., Kontos H. Effect of changes in magnesium ion concentration on cat cerebral arterioles. Am. J. Physiol. 245:1983;H22-H26.
296. Shapira S., Kadar T., Weissman B.A. Dose-dependent effect of nitric oxide synthase inhibition following transient forebrain ischemia in gerbils. Brain Res. 668:1994;80-84.
297. Shevell M.I., Silver K., O'Gorman A.M., Watters G.V., Montes J.L. Neonatal dural sinus thrombosis. Pediatr. Neurol. 5:1989;161-165.
298. Shirahata A., Nakamura T., Shimono M., Kaneko M., Tanaka S. Blood coagulation findings and the efficacy of factor XIII concentrate in premature infants with intracranial hemorrhages. Thromb. Res. 57:1990;755-763.
299. Shivji M., Kenny M., Wood R. Proliferating cell nuclear antigen is required for DNA excision repair. Cell. 69:1992;367-374.
300. Sibai B.M., Graham J.M., McCubbin J.H. A comparison of intravenous and intramuscular magnesium sulfate regimens in preeclampsia. Am. J. Obstet. Gynecol. 150:1984;728-733.
301. Siemkowicz E. Cerebrovascular resistance in ischemia. Pfluegers Arch. 388:1980;243-247.
302. Siesjö B.K. Cell damage in the brain: a speculative synthesis. J. Cereb. Blood Flow Metab. 1:1981;155-185.
303. Siesjö B.K., Bengtsson F. Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis. J. Cereb. Blood Flow Metab. 9:1989;127-140.
304. B.K. Siesjö, K. Katsura, K. Pahlmark, M.-L. Smith, The multiple causes of ischemic brain damage: a speculative synthesis, in: J. Krieglstein, H. Oberpichler-Schwenk (Eds.), Pharmacology of Cerebral Ischemia, Wissenschaftliche Verlagsgesellschaft, Stuttgart, 1992, 511 pp.
305. Silverstein F.S., Buchanan K., Hudson C., Johnston M.V. Flunarizine limits hypoxia/ischemia induced morphologic injury in immature rat brain. Stroke. 17:1986;477-482.
306. Smith M., Cen I.-T., Zan Q., Bae I., Chen C.-Y., Gilmer T., Kastan M., O'Connor P. Interaction of the p53 regulated protein Gadd45 with proliferating cell nuclear antigen. Science. 266:1994;1376-1380.
307. Soriano M.A., Tortosa A., Planas A.M., Rodriguez-Farre E., Ferrer I. Induction of HSP70 mRNA and HSP70 protein in the hippocampus of the developing gerbil following transient forebrain ischemia. Brain Res. 653:1994;191-198.
308. Spanggord H., Sheldon R.A., Ferriero D.M. Cysteamine eliminates nitric oxide synthase activity but is not protective to the hypoxic-ischemic neonatal brain. Neurosci. Lett. 213:1996;41-44.
309. Streicher E., Wiesniewski H., Klatzo I. Resistance of immature brain to experimental cerebral edema. Neurology. 15:1965;833.
310. Sutton L.N., Clark B.J., Norwood C.R., Woodford E.J., Welsh F.A. Global cerebral ischemia in piglets under conditions of mild and deep hypothermia. Stroke. 22:1991;1567-1573.
311. Swain J.A., McDonald T.J. Jr., Balaban R.S., Robbins R.C. Metabolism of the heart and brain during hypothermic cardiopulmonary bypass. Ann. Thorac. Surg. 51:1991;105-109.
312. Swann J.W., Brady R.J., Martin D.L. Postnatal development of GABA-mediated synaptic inhibition in rat hippocampus. Neuroscience. 28:1989;551-561.
313. Szabo M.D., Crosby G. Effect of profound hypermagnesemia on spinal cord glucose utilization in rats. Stroke. 19:1988;747-749.
314. Szymonowicz W., Schafler K., Cussen L.J., Yu V.Y. Ultrasound and necropsy study of periventricular haemorrhage in preterm infants. Arch. Dis. Child. 59:1984;637-642.
315. Szymonowicz W., Walker A.M., Yu V.Y., Stewart M.L., Cannata J., Cussen L. Regional cerebral blood flow after hemmorrhagic hypotension in the preterm, near-term, and newborn lamb. Pediatr. Res. 28:1990;361-366.
316. Takagi S., Cocito L., Hossmann K.-A. Blood recirculation and pharmacological responsiveness of the cerebral vasculature following prolonged ischemia of cat brain. Stroke. 8:1977;707-712.
317. Takashima S., Armstrong D.L., Becker L.E. Subcortical leukomalacia. Relationship to development of the cerebral sulcus and its vascular supply. Arch. Neurol. 35:1978;470-472.
318. S. Takashima, Pathology on neonatal hypoxic brain damage and intracranial hemorrhage. Factors important in their pathogenesis, in: Y. Fukuyama, M. Arima, K. Maekawa (Eds.), International Congress Serie No. 579. Child Neurology, Excerpta Medica, Amsterdam, 1982.
319. Tan W.K.M., Williams C.E., Gunn A.J., Mallard C.E., Gluckman P.D. Suppression of postischemic epileptiform activity with MK-801 improves neural outcome in fetal sheep. Ann. Neurol. 32:1992;677-682.
320. Tan W.K.M., Williams C.E., Gunn A.J., Mallard C.E., Gluckman P.D. Pretreatment with monosialoganglioside GM1 protects the brain of fetal sheep against hypoxic/ischemic injury without causing systemic compromise. Pediatr. Res. 34:1993;18-22.
321. Tappel A.L. Lipid peroxidation damage to cell components. Fed. Proc. 32:1973;1870-1874.
322. The Eclampsia Trial Collaborative Group Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet. 345:1995;1455-1463.
323. Thilmann R., Xie Y., Kleihues P., Kiessling M. Persistent inhibition of protein synthesis precedes delayed neuronal death in postischemic gerbil hippocampus. Acta Neuropathol. (Berlin). 71:1986;88-93.
324. Timsit S., Rivera S., Louis N.C.A., Tremblay E., Guischard F., Ouaghi P., Ben-Ari Y., Khrestchatisky M. Cyclin D1 is upregulated in regions of neuronal death during ischemia, epilepsy and in a developmental model of neuronal death. Soc. Neurosci. Abstr. 22:1996;1480.
325. Tombaugh G.C., Sapolski R.M. Mechanistic distinction between excitotoxic and acidotic hippocampal damage in an in vitro model of ischemia. J. Cereb. Blood Flow Metab. 10:1990;527-535.
326. Tominaga T., Kure S., Narisawa K., Yoshimoto T. Endonuclease activation following focal ischemic injury in the rat brain. Brain Res. 608:1993;21-26.
327. Trauner D.A., Mannino F.L. Neurodevelopmental outcome after neonatal cerebrovascular accident. J. Pediatr. 108:1986;459-461.
328. Traystman R.J., Kirsch J.R., Koehler R.C. Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J. Appl. Physiol. 71:1991;1185-1195.
329. Trifiletti R.R. Neuroprotective effects of NG-nitro-L-arginine in focal stroke in the 7-day old rat. Eur. J. Pharmacol. 218:1992;197-198.
330. Trounce J.Q., Levene M.I. Diagnosis and outcome of subcortical cystic leucomalacia. Arch. Dis. Child. 60:1985;1041-1044.
331. 2+ administered up to twenty-four hours following reperfusion prevents ischemic damage of the CA1 neurons in the rat hippocampus. Neuroscience. 44:1991;335-341.
332. Tuor U.I., del Bigio M.R. Protection against hypoxic/ischemic damage with corticosterone and dexamethasone: inhibition by glucocorticoid antagonist. J. Cereb. Blood Flow Metab. 15(Suppl. 1):1995;279.
333. Tuor U.I., Chumas P.D., Del Bigio M.R. Prevention of hypoxic/ischemic damage with dexamethasone is dependent on age and not influenced by fasting. Exp. Neurol. 132:1995;116-122.
334. Tuor U.I., del Bigio M.R., Chumas P.D. Brain damage due to cerebral hypoxia/ischemia in the neonate: pathology and pharmacological modification. Cerebrovasc. Brain Metab. Rev. 8:1996;159-193.
335. Uematsu D., Greenberg J.H., Araki N., Reivich M. Mechanisms underlying protective effects of MK-801 against NMDA-induced neuronal injury in vivo. J. Cereb. Blood Flow Metab. 11:1991;779-785.
336. Vannucci R.C. Experimental biology of cerebral hypoxia-ischemia: relation to perinatal brain damage. Pediatr. Res. 27:1990;317-326.
337. Vedder N.B., Winn R.K., Rice C.L., Chi E.Y., Arfors K.E., Harlan J.M. A monoclonal antibody to adherence promoting leukocyte glycoprotein, CD 18, reduces organ injury and improves survival from hemorrhagic shock and resuscitation in rabbits. J. Clin. Invest. 81:1988;939-944.
338. J.J. Volpe, Neurology of the Newborn, Saunders, Philadelphia, 1995.
339. von Andrian U.H., Chambers J.D., McEvoy L.M., Bargatze R.F., Arfors K.E., Butcher E.C. Two-step model of leukocyte-endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte β2 integrins in vivo. Proc. Natl. Acad. Sci. U.S.A. 88:1991;7538-7542.
340. Waga S., Hannon G., Beach D., Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature. 369:1994;574-578.
341. Ward J., Blakely W., Joner E. Mammalian cells are not killed by DNA strand breaks caused by hydroxyl radicals from hydrogen peroxide. Radiat. Res. 103:1995;383-392.
342. Wasterlain C.G., Adams L.M., Schwartz P.H., Hattori H., Sofia R.D., Wichman J.K. Posthypoxic treatment with felbamate is neuroprotective in a rat model of hypoxia/ischemia. Neurology. 43:1993;2303-2310.
343. Warner M.A., Neill K.H., Nadler J.V., Crain B.J. Regionally selective effects of NMDA receptor antagonists against ischemic brain damage in the gerbil. J. Cereb. Blood Flow Metab. 11:1991;600-610.
344. Welsh F.A., Sims R.E., Harris V.A. Mild hypothermia prevents ischemic injury in gerbil hippocampus. J. Cereb. Blood Flow Metab. 10:1990;557-563.
345. Westin B., Miller J.A., Nyberg R., Wendenberg E. Neonatal asphyxia pallida treated with hypothermia alone or with hypothermia and transfusion of oxygenated blood. Surgery. 45:1959;868-879.
346. 14C ] Leucine incorporation into proteins in gerbils after transient ischemia: relationship to selective vulnerability of hippocampus J. Neurochem. 56:1991;789-796.
347. Widmann R., Miyazawa T., Hossmann K.-A. Protective effect of hypothermia on hippocampal injury after 30 min of forebrain ischemia in rats is mediated by postischemic recovery of protein synthesis. J. Neurochem. 61:1993;200-209.
348. Wiessner C., Brinck I., Lorenz P., Neumann-Haefelin T., Vogel P., Yamashita K. Cyclin D1 messenger RNA is induced in microglia rather than neurons following transient forebrain ischemia. Neuroscience. 72:1996;947-958.
349. Williams C.E., Gunn A.J., Gluckman P.D. Time course of intracellular edema and epileptiform activity following prenatal cerebral ischemia in sheep. Stroke. 22:1991;516-521.
350. Williams C.E., Gunn A.J., Mallard C., Gluckman P.D. Outcome after ischemia in the developing sheep brain: an electroencephalographic and histological study. Ann. Neurol. 31:1992;14-21.
351. Xie Y., Seo K., Hossmann K.-A. Effect of barbiturate treatment on post-ischemic protein biosynthesis in gerbil brain. J. Neurol. Sci. 92:1989;317-328.
352. Yamashita K., Eguchi Y., Kajiwara K., Ito H. Mild hypothermia ameliorates ubiquitin synthesis and prevents delayed neuronal death in the gerbil hippocampus. Stroke. 22:1991;1574-1581.
353. Yoon H., Kim C.J., Romero R., Jun J.K., Park K.H., Choi S.T., Chi J.G. Experimentally induced intrauterine infection causes fetal brain white matter lesions in rabbits. Am. J. Obstet. Gynecol. 177:1997;797-802.
354. Yoshida N., Granger D.N., Anderson D.C., Rothlein R., Lane C., Kvietys P.R. Anoxia/reoxygenation-induced neutrophil adherence to cultured endothelial cells. Am. J. Physiol. 262:1992;H1891-H1898.
355. Yoshioka H., Kadomoto Y., Mino M., Morikawa Y., Kasubuchi Y., Kusunoki T. Multicystic encephalomalacia in liveborn twin with a stillborn macerated co-twin. J. Pediatr. 95:1979;798-800.
356. Zhang F., Xu S., Iadecola C. Time dependence of effect of nitric oxide synthase inhibition on cerebral ischemic injury. J. Cereb. Blood. Flow Metab. 15:1994;595-601.
357. Zhang F., Casey R.M., Ross M.E., Iadecola C. Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion. Stroke. 27:1996;317-323.